Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 8
Submit an article Journal homepage
291
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor

Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas

Joseph RoswarskiCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA; ;Tripler Army Medical Center, Honolulu, HI, USA; ORCID Iconhttp://orcid.org/0000-0002-1470-8814
ORCID Icon,
Mark RoschewskiCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA;
,
Christopher MelaniCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA;
,
Stefania PittalugaLaboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
,
Andrea LucasCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA;
,
Seth M. SteinbergCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA;
,
Elaine S. JaffeLaboratory of Pathology, National Cancer Institute, Bethesda, MD, USA
,
Thomas A. WaldmannCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA; ORCID Iconhttp://orcid.org/0000-0003-4500-6660
ORCID Icon &
Wyndham H. WilsonCenter for Cancer Research, National Cancer Institute, Bethesda, MD, USA; Correspondence[email protected]
 show all
Pages 2062-2066 | Received 02 Jul 2018, Accepted 30 Nov 2018, Published online: 10 Jan 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhao Jennifer C, Jaszczur Sara Mohamed, Afifi Salma & Foss Francine. (2020) Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma. Expert Review of Hematology 13:6, pages 577-583.
Read now

Articles from other publishers (5)

David Sibon. (2022) Peripheral T-Cell Lymphomas: Therapeutic Approaches. Cancers 14:9, pages 2332.
Crossref
Caiqin Xie, Xian Li, Hui Zeng & Wenbin Qian. (2020) Molecular insights into pathogenesis and targeted therapy of peripheral T cell lymphoma. Experimental Hematology & Oncology 9:1.
Crossref
Katarzyna Iżykowska, Karolina Rassek, Dorota Korsak & Grzegorz K. Przybylski. (2020) Novel targeted therapies of T cell lymphomas. Journal of Hematology & Oncology 13:1.
Crossref
Erin Mulvey & Jia Ruan. (2020) Biomarker-driven management strategies for peripheral T cell lymphoma. Journal of Hematology & Oncology 13:1.
Crossref
Robert Pytlik, Kamila Polgarova, Jana Karolova & Pavel Klener. (2020) Current Immunotherapy Approaches in Non-Hodgkin Lymphomas. Vaccines 8:4, pages 708.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.